Digestive System Diseases  >>  Signifor LAR (pasireotide long acting release)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Signifor LAR (pasireotide long acting release) / Recordati
NCT01434069: Phase I Trial of Combination of FOLFIRI and SOM 230

Completed
1
16
US
SOM230C LAR, Pasireotide LAR, FOLFIRI Infusion, 5-Fluorouracil (5FU), leucovorin (LV), and irrinotecan
H. Lee Moffitt Cancer Center and Research Institute, Novartis
Gastrointestinal Tumor
12/15
12/15

Download Options